| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |